Smarter Diagnostics.
Better Care.
Trusted partnerships that empower more effective, efficient diagnostic decision making for better animal health outcomes.


Accuplex™ Just Got Even Stronger
Accuplex™ now includes expanded screening for antibodies against three Ehrlichia species and two Anaplasma species — delivering broader regional coverage and greater diagnostic confidence.
Screen for the exposure to seven total vector-borne pathogens, including heartworm, Lyme, Ehrlichia spp. and Anaplasma spp.

Full-service support for an effective, efficient practice.

Reference Lab
North America’s largest veterinary reference laboratory network and expert medical consulting services.

In-House Diagnostics
The most comprehensive in‑clinic diagnostics portfolio on the market, including chemistry, hematology, coag, blood gas/electrolytes, digital microscopy, immunoassay, and lateral flow testing.

Imaging Equipment
The most trusted diagnostic imaging equipment and solutions — including digital radiography, ultrasound, therapeutic lasers, and CT.

Imaging Services
Fast, accurate diagnostic imaging solutions to help deliver high-quality care, including expert interpretations of radiographs, CT/MRI, ECG, and PennHip — and AI-powered solutions that increase confidence and efficiency.
In-House Diagnostics
truRapid™ FOUR
“With its speed, proven reliability, and streamlined workflow, trūRapid™ FOUR offers busy veterinary professionals a simple alternative to current testing protocols and, importantly, provides an affordable choice without compromising quality.”
— Dr. James Barr, DVM, DACVECC, Chief Medical Officer for Mars Petcare’s Science & Diagnostics

What’s new at Antech
-
Unlocking the Secrets of Exotic Animal Biopsies: Q&A with Dr. Sierra Imanse
-
Learn about advances in diagnostic imaging with 2025’s VETgirl & Antech™ Diagnostic Imaging Certificate Program
-
Antech Launches trūRapid™ FOUR: Simplifying Canine Vector-Borne Disease Screening for Veterinarians
-
Updates on Gastrointestinal Parasites with Zoonotic Potential
-
Notes on Neoplasia: A Cancer Q&A with Antech’s Director of Clinical Studies